Sigurd Broesby-Olsen, Ingunn Dybedal, Theo Gülen, Thomas K. Kristensen, Michael B. Møller, Leena Ackermann, Maria Sääf, Maria A. Karlsson, Lone Agertoft, Kim Brixen, Pernille Hermann, Eva Stylianou, Charlotte G. Mortz, Trine Torfing, Troels Havelund, Birgitta Sander, Anna Bergström, Marie Bendix, Lene H. Garvey, Ole Weis Bjerrum, Peter Valent, Carsten Bindslev-Jensen, Gunnar Nilsson, Hanne Vestergaard, Hans Hägglund
DOI: 10.2340/00015555-2325

Mastocytosis is a heterogeneous group of diseases defined by an increased number and accumulation of mast cells, and often also by signs and symptoms of mast cell activation. Disease subtypes range from indolent to rare aggressive forms. Mastocytosis affects people of all ages and has been considered rare; however, it is probably underdiagnosed with potential severe implications. Diagnosis can be challenging and symptoms may be complex and involve multiple organ-systems. In general it is advised that patients should be referred to centres with experience in the disease offering an individualized, multidisciplinary approach. We present here consensus recommendations from a Nordic expert group for the diagnosis and general management of patients with mastocytosis.